Ms. Jill Mutch, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 584 Mililani Pl Apt B, Kihei, HI 96753 Phone: 512-417-8599 |
Jayla Martinez, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 64 Kihalani St Unit 808, Kihei, HI 96753 Phone: 808-446-9992 |
Christina Marie Behar, SLP-CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 101 Kanani Rd, Kihei, HI 96753 Phone: 808-650-2014 |
Aspen Speech Therapy And Rehabilitation Llc Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 101 Kanani Rd, Kihei, HI 96753 Phone: 970-682-3743 |
Ms. Laurie Norman, M.A, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 48 Kawailani Cir, Kihei, HI 96753 Phone: 734-834-6111 |
Emily Marie Steenbergh Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 140 Uwapo Rd Apt 5-202, Kihei, HI 96753 Phone: 808-707-0266 |
Maui Chatterbox Speech Therapy L.l.c. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2747 S Kihei Rd, H205, Kihei, HI 96753 Phone: 808-359-4762 Fax: 808-419-6501 |
Victoria Chicca Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 188 Mehani Cir # A, Kihei, HI 96753 Phone: 661-477-7571 |
Mrs. Priscilla L. Omura, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 44 Kanani Rd, Kihei, HI 96753 Phone: 808-643-4480 |
Ms. Ashley Faith Jung, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2747 S Kihei Rd, H205, Kihei, HI 96753 Phone: 808-359-4762 Fax: 808-419-6501 |
Mrs. Chelsea Montoya, M.S.CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 204 Kamakoi Loop, Kihei, HI 96753 Phone: 808-344-1778 |
News Archive
A new study published in January 2020 in the European Journal of Preventive Cardiology shows that burnout could really cause your heart to fail as a result of an abnormal heart rhythm called atrial fibrillation (AF).
Remarkable new tools that spotlight individual cellular molecules are transforming biomedical research.
The prognosis of ovarian cancer is poor, with an estimated five-year survival of only 40% for advanced disease, the stage at which most ovarian carcinomas are diagnosed.
Promedior, Inc., a clinical stage biotechnology company developing novel therapeutics for the treatment of fibrosis, today announced that principal investigator, Srdan Verstovsek, MD, PhD, will present interim data from the Company's ongoing Phase 2 clinical trial of its lead product candidate, PRM-151, for the treatment of myelofibrosis, in a poster presentation on June 2, 2014 at the American Society for Clinical Oncology 2014 Annual Meeting.
› Verified 1 days ago